Grants and Contracts Details
Description
Human Clinical Trial - Confidential. Abstract
This is a platform protocol designed to be flexible so that it is suitable for a
range of interventions and settings within diverse health care systems and
community settings with incorporation into clinical COVID-19 management
programs and treatment plans if results achieve key study outcomes.
This protocol is a prospective, multi-center, multi-arm, randomized,
controlled platform trial evaluating interventions to address and improve
exercise intolerance and post-exertional malaise (PEM) as manifestations
of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC).
The focus of this protocol is to assess interventions that can improve
exercise capacity, daily activities tolerance, and quality of life in patients
with PASC.
Status | Active |
---|---|
Effective start/end date | 3/1/24 → 12/31/26 |
Funding
- Duke University: $2.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.